ICICI Lombard to Sun Pharma: 10 stocks for steady long-term gains

116

Stocks for long-term returns

Analysts have chosen 10 amazing stocks for long-term returns that could become return machines. These stocks have the potential to generate substantial profits. Check out the list.

216

Power stocks

With the stock market closed for 3 days, start the next week with these 6 power stocks. Each stock has the potential for Rs 3500 profit; the income stream will continue in these power stocks!

316

Hindustan Aeronautics Limited

Brokerage firm Motilal Oswal recommends buying shares of defense stock Hindustan Aeronautics Limited. The company has an order book of ₹1.8 lakh crore until March 2025.

416

Potential contract

A new potential contract worth ₹6 lakh crore is also in the pipeline, which could be completed in the coming years.

516

Revenue and growth

This will increase the company's revenue and growth, and will also have an impact on the share.

616

Target price

The brokerage firm has set a target price of ₹5,100 for this share. Currently, the price of this stock is ₹4,220.

716

ABB India

Motilal Oswal has given a buy rating on the shares of ABB India, a company that provides electrical equipment and automation solutions.

816

Strong balance sheet

The brokerage says that the company's strong balance sheet and growing order provide a great opportunity for long-term investment. Its target price has been given as ₹6,700. Currently, the stock is priced at ₹5,565.

916

ICICI Lombard General Insurance

Motilal Oswal has advised to keep the shares of insurance sector company ICICI Lombard General Insurance in the portfolio. Its target price has been given as ₹2,200. Currently, the stock is priced at ₹1,789.80.

1016

Prestige Estate

Brokerage firm Motilal Oswal has also recommended buying shares of Prestige Estate.

1116

Returns of up to 42%

Its target price has been given as ₹1,725. Currently, this stock is priced at ₹1,215. From here, the stock can give returns of up to 42%.

1216

Ajanta Pharma

Global brokerage firm Jefferies has recommended betting on the shares of Ajanta Pharma. Its target price has been given as ₹2,850.

1316

Branded generic drugs

Currently, the stock is priced at ₹2,691.50. The brokerage's report states that 70% of the company's revenue comes from branded generic drugs. Competition is low and profits are good in this sector. The company is quite strong in this case. As a result, the stock may benefit.

1416

Mahindra & Mahindra

Brokerage firm PL Capital Group has given a buy rating on the shares of Mahindra & Mahindra. Its target price has been given as ₹3,218. Currently, the stock is priced at ₹2,675.30. In this way, one can get returns of up to 20% from the share.

1516

Sun Pharma

Brokerage firm MK Global Financial Services, in their report dated April 10, recommended keeping Sun Pharma's stock in the portfolio. Its target price has been given as ₹2,400, which is about 37% higher than the current price of ₹1,757.

1616

MK Global Financial Services

MK Global Financial Services recommends holding Delivery stock in the portfolio. In a report published on April 6, 2025, the brokerage set their target price at ₹400, which is approximately 42% higher than the current price of ₹281.